Christian Schneider-Fresenius

Statistics

Publications

Citations

446

H-Index

Active since

1996

Affiliations

Eli Lilly (Germany)(Current)

Heidelberg University

University of Konstanz

University of Cologne

Christian Schneider-Fresenius is an author at Eli Lilly (Germany) specializing in psychopharmacology, attention-deficit/hyperactivity disorder, and adhd pharmacotherapy.

Publications per year

1996–2012

Publications

Autoimmunity and Inflammation Due to a Gain-of-Function Mutation in Phospholipase Cγ2 that Specifically Increases External Ca2+ Entry

Philipp Yu, Rainer Constien, Neil Dear et al. · Immunity · 2005 · 183 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Molecular characterization of glucokinase from Escherichia coli K-12

Daniel Meyer, Christian Schneider-Fresenius, Reinhold Horlacher et al. · Journal of Bacteriology · 1997 · 141 citations

Life Sciences, Biochemistry, Molecular Biology +11

Atomoxetine Versus Placebo in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder: A Double-Blind, Randomized, Multicenter Trial in Germany

Alexander Schacht, Karin Helsberg, Christian Schneider-Fresenius et al. · Journal of Child and Adolescent Psychopharmacology · 2011 · 45 citations

Medicine, Pharmacotherapy, Psychiatry +17

Does Atomoxetine Improve Executive Function, Inhibitory Control, and Hyperactivity?

Peter M. Wehmeier, Alexander Schacht, Fredrik Ulberstad et al. · Journal of Clinical Psychopharmacology · 2012 · 30 citations

Medicine, Pharmacology, Pharmacotherapy +17

Effect of atomoxetine on quality of life and family burden: results from a randomized, placebo-controlled, double-blind study in children and adolescents with ADHD and comorbid oppositional defiant or conduct disorder

Peter M. Wehmeier, Alexander Schacht, Karin Helsberg et al. · Quality of Life Research · 2010 · 25 citations

Medicine, Pharmacotherapy, Psychiatry +17

1–5 of 6